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ABSTRACT 
 
 
 
Hemodialysis is one of the applied membrane technologies that is regarded as 
a life-saving therapy for patients with impaired kidneys. It purifies blood toxins outside 
of the patient’s body using a dialyzer as a kidney replacement. Synthetic materials such 
as polyethersulfone (PES) polymer are currently being used to fabricate the dialyzer 
membrane for hemodialysis. However, the blood compatibility or hemocompatibility 
of these materials are still inadequate and administration of an anticoagulant (heparin) 
is required throughout the dialysis procedure to avoid blood clotting. Therefore this 
study aimed at developing a biocompatibility membrane for hemodialysis application.  
In this study, poly (1,8-octanediol citrate) (POC) that synthesized through a simple 
polycondesation method was used to enhance membrane biocompatibility. Different 
compositions of POC (0-3%) were added into polyethersulfone (PES) dope solutions 
to fabricate modified biocompatible PES membranes via the phase-inversion 
technique. The biocompatibility of the modified PES membranes was evaluated by 
human serum fibrinogen (FBG) protein adsorption, platelet adhesion, activated partial 
thromboplastin time (APTT) and prothrombin time (PT), thrombin–antithrombin III 
(TAT), complement (C3a and C5a) activation and Ca2+ absorption on membrane. 
Results showed that higher POC wt.% caused a 31% reduction of FBG adsorption, less 
platelets adhesion, prolonged APTT (11.1 seconds) and PT (2.5 seconds), lower TAT 
activation, suppressed C5a and C3a activation and absorbed 35% more Ca2+ ion 
compared to pristine PES membrane. These results indicated that modified PES 
blended POC has good biocompatibility properties, suggesting potential application in 
the field of blood purification, especially in hemodialysis. 
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ABSTRAK 
 
 
 
 
Hemodialisis merupakan antara aplikasi dalam teknologi membran yang dapat 
menyelamatkan nyawa pesakit yang mengalami masalah buah pinggang. Ia 
membersihkan toksin darah diluar badan pesakit menggunakan dialiser sebagai 
pengganti kepada buah pinggang. Bahan sintetik seperti polimer polietersulfon (PES) 
digunakan sebagai bahan utama untuk membuat membran dialiser untuk hemodialisis. 
Walau bagaimanapun, keserasian antara darah dan bahan sintetik ini masih tidak 
mencukupi dan anti-beku darah (heparin) diperlukan sepanjang prosedur dialisis untuk 
mengelakkan pembekuan darah berlaku. Objektif kajian ini adalah bertujuan untuk 
membangunkan satu membran bioserasi yang baru bagi digunakan dalam aplikasi 
hemodialisis. Dalam kajian ini, poli(1,8-octanediol citrate) (POC) yang disintesis 
melalui kaedah polikondensasi mudah telah digunakan untuk meningkatkan 
bioserasian dengan membran. Komposisi POC yang berbeza (0-3%) telah ditambah 
pada larutan polimer PES untuk membuat membran PES yang diubahsuai melalui 
teknik fasa penyongsangan. Keserasian-bio membran PES yang diubahsuai telah 
dinilai dengan penjerapan protein fibrinogen serum (FBG), kebolelekatan platelet, 
masa separa-aktif tromboplastin (APTT) dan masa prothrombin (PT), pengaktifan 
thrombin-antithrombin III (TAT), pengaktifan komplimen (C3a dan C5a) dan 
penyerapan Ca2+ ion pada membran. Hasil kajian menunjukkan bahawa dengan wt.% 
POC yang tinggi, telah mengurangkan 31% penjerapan FBG, mengurangkan platelet 
melekat, memanjangkan  masa APTT (11.2 saat) dan PT (2.5 saat) lebih lama, 
pengaktifan TAT yang rendah,  mengurangkan  pengaktifan C5a dan C3a dan 
menyerap lebih 35% ion Ca2+ berbanding membrane asal. Dapatan kajian ini 
menunjukkan bahawa membran yang diubahsuai dengan campuran POC mempunyai 
kebioserasian yang lebih baik bagi menyediakan aplikasi membran yang lebih 
praktikal dalam bidang pembersihan darah, terutamanya bagi aplikasi hemodialisis. 
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CHAPTER 1  
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background of Research 
 
 
Since the breakthrough in 1978 by french cleric, J. Abbé Nollet, membrane 
technology was only being studied by scientist in 1960s for its commercialization in 
industrial application (Fane et al., 2011).  In 1960s, Loeb and Sourirajan developed 
asymmetric membrane for industrial applications (Kołtuniewicz, 2005). Then in 1980s, 
techniques such as reverse osmosis, ultrafiltration, microfiltration and electrodialysis 
resulted in worldwide membrane commercialize applications in large scale plants 
(Baker, 2012; Fane et al., 2011). After years of rapid development of the membrane 
technology, the applications of membranes was used in the development of membranes 
for medical separation processes, in particular, the artificial kidney (hemodialysis) 
(Baker, 2012). 
 
Kidney is a vital organ in human composed of millions unit of filter which 
remove excess waste products and fluid out of the body. This function is essential for 
normal homeostasis in maintaining body fluid and chemical composition inside the 
body. Damage to the kidney may lead to the reduction in its performance. 
Subsequently, the damage result in build-up of toxins and excess fluid that may affect 
health.  A therapy called renal replacement therapy (RRT) or commonly known as 
hemodialysis is required to overcome the problem. 
 
Hemodialysis is highly successful lifesaving and life sustaining therapy for 
renal failure patient (Vilar & Farrington, 2011). In 2012, there were 28,590 patients 
receiving dialysis in Malaysia, and vast majority (92%) of these patients are on 
2 
 
hemodialysis (Lim et al., 2013). According to Datuk Seri Dr. Hasan Abdul Rahman 
Malaysian Health director-general, every year a patient in average had to spend about 
RM 33,000.00 for dialysis treatment and more than RM 700 million for total dialysis 
patients (Arukesamy, 2011). However, 60% of the cost was government subsidized. 
Therefore, Malaysian government spent almost RM 420 million for dialysis 
operational cost only (include staff salaries, consumables e.g., dialyser reuse 3 times, 
blood lines, CAPD system and dialysate), equipment maintenance and utilities) which 
do not include associate medical cost (RM 270/patient), capital cost and general 
hospital cost (RM 360/patient) (Lim et al., 1999). 
 
In general, the process of dialysis involve two way movement of molecules 
across a semipermeable membrane. Clinically, this movement takes place in and out 
of blood, across a semipermeable membrane. The blood is exposed to an artificial 
membrane outside of the body, the process is called hemodialysis (HD) or 
hemofiltration (HF) (Ahmad, 2009). The dialyzer made of dialysis membrane is the 
most critical and important part of dialysis set up form separate adjacent paths for 
blood and dialysate, which flow on opposite sides of the membrane in opposite 
directions to maximize diffusion gradients. According to Malaysian Hemodilaysis 
Quality and Standard (2012) published by Ministry of Health Malaysia a dialyzers 
should be made from biocompatible membrane and approved by regulatory authorities 
in USA, Europe, Japan or local equivalent. 
 
In selecting the material for hemodialysis, benchmarks such as 
biocompatibility towards white blood cell and complement system, impermeability 
toward dialysate impurities, adsorption capacity and pore size must be considered 
(Boure, 2004). The success of hemodialysis is highly dependent on the membrane used 
(Gautham et al., 2013). The earlier type of material used in the making of dialysis 
membrane was the cellulose based membrane (e.g.; cuprophane). Later, due to certain 
undesired effect such as immunological reaction, the cellulose was substituted by other 
material like mixed-cellulosic synthetic membrane (e.g.; Hemophan). Currently, the 
synthetic membrane (e.g; polyethersulfone (PES), polysulfone (PS), polyacrylonitrile 
(PAN), polycarbonate, polymethylmethacrylate (PMMA), and polyamide) is the latest 
type of material commonly used to produce dialysis membrane (Ahmad, 2009). 
Moreover, aside from having better performance in removing middle molecule (500-
3 
 
15000 Da) and β2-microglobulin, the synthetic membranes also comprise higher 
biocompatibility properties (Kerr & Huang, 2010; Macleod et al., 2005). 
 
Here, in this study PES is used as a material to fabricate dialysis membrane. 
The PES membranes are widely employed in biomedical fields such as artificial organs 
and medical devices used for blood purification, e.g., hemodialysis, hemodiafiltration, 
hemofiltration, plasmapheresis and plasma collection (Su et al., 2011). In order to 
achieve the production of high biocompatibility dialysis membrane a citric acid 
derived biodegradable elastomers (CABEs) was added as additive. This new class of 
biomaterials is all synthesized with non-toxic monomers using simple and cost 
effective procedures. These materials share one common monomer named citric acid, 
which is a non-toxic metabolic product of the Krebs cycle. In addition to the sodium 
form of citric acid, sodium citrate, is an anticoagulant currently used in hospitals. Thus, 
CABEs may also possess suitable hemocompatibility for blood contacting applications 
(Tran et al., 2009).  
 
A novel biodegradable elastomer, poly (1, 8-octanediol-co-citrate) (POC) is 
synthesized and used as biocompatible additives to produce biocompatible modified 
PES flat-sheet membranes. The fabricated membranes are characterized for its 
physical and chemical properties. The dialysis performance of the modified membrane 
also been evaluated. The biocompatibility of the modified membranes are analyzed by 
studying the membrane blood compatible properties. 
   
 
 
 
1.2 Problem Statement 
  
 
In blood-contacting membrane application such as hemodialysis, the protein 
adsorption on the membrane surface cause some serious problem to membrane 
performance. The adsorption of protein on membrane surface eventually lead to 
membrane fouling resulting in flux declining and reduction of membrane selectivity. 
Furthermore, the adsorbed proteins plugged membrane pores affecting efficacy, by 
decreasing the pore size of the membrane and prevent transmembrane crossing for 
waste and solutes. Membrane protein adsorption may be caused by few factors such 
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as the membrane surface chemistry, morphology, hydrophilicity and also the adsorbed 
protein size, charge, shape, pH value, and so on. Besides causing membrane fouling 
that affect membrane performance, adsorption of protein also leads to membrane 
biocompatibility problems (Sun et al., 2003). 
 
Biocompatibility of the membrane is one of the important aspect in developing 
a membrane for hemodialysis. It is the biological reaction between dialysis membrane 
and the blood. Exposure of dialysis membrane to blood leads to normal physiological 
response of blood components such as activation of platelets, inflammatory response, 
complement blood cells, and complement cascade (Ahmad, 2009; Gawaz et al., 1999) 
which may cause adverse effect to the dialysis patient. Activation and adhesion of the 
platelet on the membrane surface cause coagulation of blood (Sperling et al., 2009). 
Therefore, to avoid coagulation an anticoagulant such as heparin is used in the dialysis 
system. Yet, the usage of heparin causes several complication to dialysis patient like 
heparin-induced thrombocytopenia (HIT) Type II and bleeding that might lead to 
severe morbidity and mortality (Suranyi & Chow, 2010). Therefore, effective 
membrane with higher biocompatibility to perform sufficient hemodialysis is an 
important key to cope with the rising demands from kidney failure patient. 
 
   
 
 
1.3 Objectives of Study 
 
 
Based on the problem statement, the aim of this study was to reduce the incidence 
of membrane compatible reaction and membrane fouling in the dialyzer. Therefore, 
this study sought to produce a new biocompatible synthetic polymer membrane to 
perform sufficient hemodialysis and to cope with the rising demands from kidney 
failure patient in Malaysia. The objectives of this research are: 
 
1. To synthesize poly(1,8-octanediol citrate) (POC) as additive to improve PES 
membrane biocompatibility 
2. To fabricate and characterize physical and chemical properties of the modified 
PES flat-sheet membrane with different POC wt.% loading (0-3%). 
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3. To evaluate the biocompatibility of the modified PES/POC flat-sheet 
membranes different POC wt.% loading (0-3%) for hemodialysis applications. 
 
 
 
 
1.4 Scope of Study 
 
 
1. Preparation of poly(1,8-octane citrate) (POC) via simple polycondensation 
method. 
2. Characterization of the POC with Attenuated Total Reflectance-Fourier 
Transform Infrared Spectroscopy (ATR-FTIR), proton Nucleus Magnetic 
Resonance (1H NMR), Matrix-Assisted Laser Desorption Ionization-Time of 
Flight Mass Spectrometry (MALDI-TOF). 
3. Dope preparation for different wt.% loading (0-3%) concentration of POC 
blend PES membranes. 
4. Fabrication of modified PES membranes via liquid-liquid phase inversion 
method. 
5. Characterization of modified PES membranes by ATR-FTIR, scanning 
electron microscope (SEM), atomic-force microscopy (AFM), 
Thermogravimetric Analysis (TGA), zeta-potential, membrane wettability, 
membrane porosity and pore size. 
6. Evaluation of the modified membranes’ performance for pure water flux, 
solute rejection and uremic toxins clearance. 
7. Evaluation of the modified membranes biocompatibility through protein 
adsorption, platelet adhesion, plasma coagulation time, calcium ion absorption 
and coagulation and complement activation. 
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1.5 Significance of Study 
 
 
The number of dialysis patient in Malaysia is rapidly increasing each and every 
year. Data from 22nd Report of the Malaysian Dialysis 2015 and Transplant Registry 
by the National Renal Registry showed the number of dialysis patient in Malaysia was 
steeply increase for the last 10 years from 13000 in 2004 and at least 35000 people in 
2015. Each year the amount of  new dialysis patient increase with 6107 new people 
need dialysis in 2014 (Goh & Ong, 2015). Herein Malaysia, there are few researchers 
that currently doing research on dialysis membrane but not to be commercialize. None 
of them focuses on improving biocompatibility of hemodialysis membrane and only 
study on membrane performances. Nowadays, local dialysis center and hospital still 
use an imported dialyzer which can be costly. Therefore, this study aims to produce 
locally produced high performance biocompatible hemodialysis membrane which 
eventually can reduce current dialyzer cost in Malaysia. 
 
Dialyzer or artificial kidney is the heart of the dialysis which contain a semi-
permeable membrane that function as kidney replacement. Nowadays, synthetic 
polymer such as polyethersulfone (PES) is being used to make dialysis membrane due 
to excellent physical and chemical properties. However, the hydrophobic nature of the 
polymer tends to adsorb protein and cause membrane bio-incompatibility that lead to 
thrombosis. Several modification have been made to improve membrane 
biocompatibility with anti-coagulant properties, for example by using a heparin (anti-
coagulant) to modified membrane through coating (AN69ST) or grafting it on 
membrane surface (Morena et al., 2010; Tang et al., 2012). These modified membrane 
allows heparin-free dialysis which can reduce adverse events from prolong usage of 
heparin such as heparin induced thrombocytopenia (HIT). 
 
The significance of this current research is by studying the development of 
modified PES dialysis membranes that blended with POC to improve it 
biocompatibility. Previous study had found that POC exhibit a biocompatible 
properties for blood contacting application, hence modification of the PES dialysis 
membrane with POC can improve biocompatibility of membrane and prevent 
7 
 
thrombosis formation on membrane surface. Therefore, by using this PES blend POC 
dialysis membrane, an anticoagulant free dialysis can be perform. 
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